The Saudi Industrial Investment Group (SIIG), one of the first privately owned petrochemical companies in Saudi Arabia, is ploughing around US$70m into Unibio.
The companies say advanced discussions are underway to build a site five times the size of their single cell protein (SCP) fermenter facility in China.
Unibio’s licensing partner, the Doha-based industrial biotech investor, Gulf Biotech, has reached the final stages before construction in the first single-cell protein (SCP) plant project in Qatar.
Texas, US based, Core Protein LLC, is bringing a court case against Unibio US APS over the protein innovator’s alleged threatened termination of an exclusive licensing agreement.
Single cell protein developer, Unibio, today announced the successful completion of a US$15m bridge round financing, predominantly from existing shareholders.
Under a new agreement, Stafilies, the parent company of Russian based Uniprotein production licensee, Protelux, will buy a shareholding in Danish feed protein player, Unibio, in exchange for cash and intellectual property.